Opportunity Information: Apply for HRSA 19 028
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity is a discretionary grant program run by the U.S. Department of Health and Human Services through the Health Resources and Services Administration (HRSA). It sits under the Ryan White HIV/AIDS Program (RWHAP) Part B and is administered by HRSA's HIV/AIDS Bureau (HAB), specifically the Division of State HIV/AIDS Programs (DSHAP). The basic purpose of this funding is to give states and territories targeted, short-term relief when their ADAP programs are at risk of not being able to serve everyone who qualifies, with the central goal of preventing, reducing, or eliminating ADAP waiting lists. In practical terms, it is meant to protect access to HIV medications and related support when budgets, enrollment changes, or drug and insurance costs threaten program capacity.
The key driver for awards under this program is demonstrated need. Applicants have to make a clear case that they require additional resources to avoid creating a waiting list or to quickly resolve one if it exists. HRSA emphasizes that decisions will be based on how well an applicant can justify this need using the criteria laid out in the notice of funding opportunity (NOFO). Applications are reviewed by an external objective review committee, and the review prioritizes situations where there is an existing waiting list or an imminent risk that a waiting list will appear. Even though this particular NOFO notes that, at the time it was published, there were no ADAP waiting lists nationwide, HRSA continues the ERF initiative to keep the safety net stable, maintain the infrastructure needed to respond rapidly, and reduce the chance that states or territories will have to reintroduce waiting lists during future funding or cost pressures.
Funding can be used not only for direct ADAP-related costs that affect access to medications, but also for cost-containment strategies that help programs stretch dollars while keeping clients covered. One specific example named in the opportunity is providing health insurance assistance, which can shift some medication costs away from ADAP while preserving or improving access for clients. The underlying idea is to support strategies that maintain continuous treatment access, stabilize enrollment, and keep the program financially sustainable so eligible clients are not delayed or denied services due to resource constraints.
A notable compliance point in the NOFO is that states and territories are expected to immediately report any waiting list to HRSA if one exists. If an applicant has not reported a waiting list but does have one, HRSA directs them to report it right away and then use any awarded ERF funds specifically to remove clients from that waiting list. This underscores that ERF dollars are intended to directly address access barriers and that HRSA is monitoring waiting list status closely as a core program outcome.
In addition to the waiting-list focus, applicants are encouraged to frame proposed activities in ways that align with HRSA priorities such as innovation, collaboration, impact, and effectiveness. That typically means describing approaches that are not just temporary fixes, but that improve how ADAP coordinates with other systems (like Medicaid, marketplace plans, or other Ryan White services), uses data to manage costs and client needs, and produces measurable results in maintaining coverage and timely access to therapy.
From the posting details provided, the opportunity number is HRSA-19-028 and the CFDA number is 93.917, with an original application closing date of October 25, 2018, and an estimated 15 awards. The award ceiling is listed as 0, which usually signals that the NOFO does not specify a single maximum award amount in that field and that awards may vary based on documented need, available appropriations, and HRSA determinations. Eligibility is summarized broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the program description makes clear that the intended applicants are states and territories operating ADAP under RWHAP Part B, since the purpose is to stabilize those jurisdictional programs and prevent or eliminate ADAP waiting lists.Apply for HRSA 19 028
- The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917.
- This funding opportunity was created on Jun 25, 2018.
- Applicants must submit their applications by Oct 25, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 15 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
ADAP Emergency Relief Funds (ERF) - FAQs
What is the ADAP Emergency Relief Funds (ERF) grant opportunity?
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity is a discretionary grant program administered by the U.S. Department of Health and Human Services (HHS) through the Health Resources and Services Administration (HRSA). It is part of the Ryan White HIV/AIDS Program (RWHAP) Part B and is administered within HRSA by the HIV/AIDS Bureau (HAB), specifically the Division of State HIV/AIDS Programs (DSHAP).
What is the main purpose of ADAP ERF funding?
The core purpose is to provide states and territories targeted, short-term relief when their ADAP programs are at risk of not being able to serve all eligible clients. The central goal is preventing, reducing, or eliminating ADAP waiting lists, helping protect access to HIV medications and related support when budgets, enrollment changes, or drug and insurance costs threaten program capacity.
What problem is this funding designed to address?
This funding is designed to address situations where an ADAP program may have, or may soon have, insufficient resources to cover all qualified clients. It focuses on avoiding the creation of waiting lists and quickly resolving waiting lists if they occur so eligible clients are not delayed or denied access to needed HIV medications and support.
Which HRSA program does this sit under?
ADAP ERF sits under the Ryan White HIV/AIDS Program (RWHAP) Part B. It is administered by HRSA's HIV/AIDS Bureau (HAB), within the Division of State HIV/AIDS Programs (DSHAP).
Who is the intended applicant for this opportunity?
Although eligibility is summarized in the posting as "Others (see text field entitled Additional Information on Eligibility for clarification)," the program description indicates the intended applicants are states and territories operating ADAP under RWHAP Part B, because the purpose is to stabilize those jurisdictional ADAP programs and prevent or eliminate ADAP waiting lists.
Is this a formula grant or a discretionary grant?
This opportunity is described as a discretionary grant program run by HHS through HRSA.
How does HRSA decide whether to make an award?
The key driver is demonstrated need. Applicants must make a clear case that additional resources are required to avoid creating a waiting list or to quickly resolve an existing waiting list. HRSA emphasizes that award decisions are based on how well an applicant justifies need using the criteria laid out in the Notice of Funding Opportunity (NOFO).
What types of situations are prioritized during review?
Applications are reviewed with priority given to situations where there is an existing waiting list or an imminent risk that a waiting list will appear. The NOFO emphasizes waiting list status and the risk of inability to serve all eligible clients as a core consideration.
Who reviews applications for this funding?
Applications are reviewed by an external objective review committee, as stated in the opportunity description.
Were there ADAP waiting lists at the time this NOFO was published?
The NOFO notes that at the time it was published, there were no ADAP waiting lists nationwide. However, HRSA continues the ERF initiative to keep the safety net stable and preserve the ability to respond rapidly if future funding pressures or cost increases threaten program capacity.
Why does HRSA continue ERF if there were no waiting lists at the time?
HRSA continues ERF to maintain a stable safety net, keep the infrastructure in place to respond quickly, and reduce the likelihood that states or territories will need to reintroduce waiting lists in the future due to funding shortfalls, rising drug costs, insurance costs, or other pressures.
What can ERF funds be used for?
Funding can be used for direct ADAP-related costs that affect access to medications, as well as for cost-containment strategies that help programs stretch available resources while keeping clients covered. The opportunity emphasizes protecting continuous access to HIV treatment and stabilizing program capacity.
Does the NOFO provide examples of allowable strategies?
Yes. One specific example named is providing health insurance assistance. This can shift some medication costs away from ADAP while preserving or improving access for clients, supporting continuous treatment and program sustainability.
What is the role of cost-containment strategies in this opportunity?
Cost-containment strategies are highlighted as a way to stretch program dollars while maintaining coverage and access. The underlying intent is to help keep eligible clients continuously served and to reduce the chance that resource constraints translate into delays, denials, or waiting lists.
What are the reporting expectations related to waiting lists?
States and territories are expected to immediately report any ADAP waiting list to HRSA if one exists. Waiting list status is treated as a closely monitored outcome and a major compliance and programmatic focus in the NOFO.
What if a state or territory has a waiting list but has not reported it?
If an applicant has not reported a waiting list but does have one, HRSA directs the jurisdiction to report it right away. The NOFO further indicates that any awarded ERF funds should then be used specifically to remove clients from that waiting list.
What outcomes is ERF funding ultimately trying to produce?
The stated central outcome is to prevent, reduce, or eliminate ADAP waiting lists and protect timely access to HIV medications and related support. The broader intent is to maintain continuous treatment access, stabilize enrollment, and keep ADAP financially sustainable so qualified clients are not delayed or denied services due to limited resources.
How should applicants frame proposed activities to align with HRSA priorities?
Applicants are encouraged to describe activities that align with HRSA priorities such as innovation, collaboration, impact, and effectiveness. In practical terms, this means describing approaches that strengthen coordination with other systems (such as Medicaid, marketplace plans, or other Ryan White services), use data to manage costs and client needs, and show measurable results in maintaining coverage and timely access to therapy.
What is the opportunity number for this NOFO?
The opportunity number provided is HRSA-19-028.
What is the CFDA number for this program?
The CFDA number listed is 93.917.
What was the original application closing date?
The original application closing date provided is October 25, 2018.
How many awards were estimated?
The posting details provide an estimate of 15 awards.
Is there a maximum award amount (ceiling) listed?
The award ceiling is listed as 0. This typically indicates the NOFO does not specify a single maximum award amount in that field and that awards may vary based on documented need, available appropriations, and HRSA determinations.
What is the most important factor an applicant needs to show?
Demonstrated need is emphasized as the central factor. Applicants must clearly justify why additional resources are necessary to prevent a waiting list from forming or to eliminate one quickly if it exists, using the criteria described in the NOFO.
Browse more opportunities from the same category: Health
Next opportunity: Conservation Technical Asistance in outreach,
Previous opportunity: Libya Security Sector Planning
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 19 028
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 19 028) also looked into and applied for these:
| Funding Opportunity |
|---|
| Preventive Health and Health Services Block Grant– 2018 Apply for CDC RFA OT18 1805 Funding Number: CDC RFA OT18 1805 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Limited Competition: Human Heredity and Health in Africa Consortium Biorepository (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 020 Funding Number: RFA RM 18 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA AG 19 011 Funding Number: RFA AG 19 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $3,300,000 |
| Health Equity and Financial Protection Platform (HEFPP) Apply for 72049218APS00001 03 Funding Number: 72049218APS00001 03 Agency: Agency for International Development, Philippines USAID-Manila Category: Health Funding Amount: $11,500,000 |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 16320401SUPP18 Funding Number: CDC RFA GH15 16320401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 16210401SUPP18 Funding Number: CDC RFA GH15 16210401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity, and Security Apply for CDC RFA GH15 16270301SUPP18 Funding Number: CDC RFA GH15 16270301SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,000,000 |
| Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam Apply for CDC RFA GH16 17180301SUPP18 Funding Number: CDC RFA GH16 17180301SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,000,000 |
| Health Leadership Project (HLP) Apply for 72052118RFA00005 Funding Number: 72052118RFA00005 Agency: Agency for International Development, Haiti USAID-Port Au Prince Category: Health Funding Amount: $15,000,000 |
| Rural Communities Opioid Response Program - Technical Assistance Apply for HRSA 18 124 Funding Number: HRSA 18 124 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 19 006 Funding Number: HRSA 19 006 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Screening and Treatment for Maternal Depression and Related Behavioral Disorders Program Apply for HRSA 18 101 Funding Number: HRSA 18 101 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Technical Assistance to Central Asian National HIV Programs to Achieve and Sustain HIV Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1917 Funding Number: CDC RFA GH19 1917 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement Apply for CDC RFA OT18 18030101SUPP18 Funding Number: CDC RFA OT18 18030101SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $3,000,000 |
| Support of Strategic Information Activities in the Kingdom of Lesotho under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1925 Funding Number: CDC RFA GH19 1925 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,300,000 |
| Newborn Screening State Evaluation Program Apply for HRSA 18 125 Funding Number: HRSA 18 125 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $60,000 |
| Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children Apply for CDC RFA EH18 1806 Funding Number: CDC RFA EH18 1806 Agency: Department of Health and Human Services, Centers for Disease Control - NCEH Category: Health Funding Amount: $500,000 |
| Supporting Laboratory Strengthening Activities and Partnerships for Countries Supported under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1935 Funding Number: CDC RFA GH19 1935 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $50,000,000 |
| HIV Technical Assistance in Burma under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1905 Funding Number: CDC RFA GH19 1905 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,890,000 |
| Tribal Management Grant Program Apply for HHS 2018 IHS TMD 0001 Funding Number: HHS 2018 IHS TMD 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 19 028", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.